vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and Kentucky First Federal Bancorp (KFFB). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.8M, roughly 1.4× Kentucky First Federal Bancorp). On growth, Kentucky First Federal Bancorp posted the faster year-over-year revenue change (28.3% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs 24.0%).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
Kentucky First Federal Bancorp is a U.S. regional bank holding company based in Kentucky. It offers retail and commercial banking services including deposits, mortgage loans, consumer lending and small business financing, serving local individual customers and small-to-medium enterprises across its Kentucky operating regions.
IRD vs KFFB — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $2.8M |
| Net Profit | — | $304.0K |
| Gross Margin | — | — |
| Operating Margin | — | 14.1% |
| Net Margin | — | 10.7% |
| Revenue YoY | -10.2% | 28.3% |
| Net Profit YoY | 53.0% | 2238.5% |
| EPS (diluted) | — | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $2.8M | ||
| Q3 25 | $3.1M | $2.7M | ||
| Q2 25 | $2.9M | $2.4M | ||
| Q1 25 | $4.4M | $2.2M | ||
| Q4 24 | $4.3M | $2.2M | ||
| Q3 24 | $3.9M | $2.0M | ||
| Q2 24 | $1.1M | $2.0M | ||
| Q1 24 | $1.7M | $1.8M |
| Q4 25 | — | $304.0K | ||
| Q3 25 | $-17.5M | $344.0K | ||
| Q2 25 | $-7.4M | $176.0K | ||
| Q1 25 | $-8.2M | $7.0K | ||
| Q4 24 | — | $13.0K | ||
| Q3 24 | $-7.5M | $-15.0K | ||
| Q2 24 | $-7.8M | $-1.1M | ||
| Q1 24 | $-7.1M | $-107.0K |
| Q4 25 | — | 14.1% | ||
| Q3 25 | -269.9% | 17.0% | ||
| Q2 25 | -309.0% | 10.3% | ||
| Q1 25 | -227.2% | 0.7% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | -207.1% | -1.0% | ||
| Q2 24 | -748.9% | -58.7% | ||
| Q1 24 | -450.5% | -7.9% |
| Q4 25 | — | 10.7% | ||
| Q3 25 | -566.9% | 12.9% | ||
| Q2 25 | -257.5% | 7.6% | ||
| Q1 25 | -187.5% | 0.3% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | -194.6% | -0.7% | ||
| Q2 24 | -698.3% | -56.7% | ||
| Q1 24 | -415.3% | -5.8% |
| Q4 25 | — | $0.04 | ||
| Q3 25 | $-0.25 | $0.04 | ||
| Q2 25 | $-0.12 | $0.02 | ||
| Q1 25 | $-0.24 | $0.00 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | $-0.29 | $0.00 | ||
| Q2 24 | $-0.30 | $-0.13 | ||
| Q1 24 | $-0.29 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $19.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.3M | $49.1M |
| Total Assets | $50.2M | $375.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $19.7M | ||
| Q3 25 | $30.8M | $14.6M | ||
| Q2 25 | $32.4M | $19.5M | ||
| Q1 25 | $41.8M | $27.8M | ||
| Q4 24 | $30.3M | $21.0M | ||
| Q3 24 | $36.6M | $17.3M | ||
| Q2 24 | $41.4M | $18.3M | ||
| Q1 24 | $47.2M | $15.4M |
| Q4 25 | $15.3M | $49.1M | ||
| Q3 25 | $6.0M | $48.8M | ||
| Q2 25 | $17.5M | $48.4M | ||
| Q1 25 | $5.1M | $48.2M | ||
| Q4 24 | $6.7M | $48.1M | ||
| Q3 24 | $34.3M | $48.2M | ||
| Q2 24 | $40.6M | $48.0M | ||
| Q1 24 | $46.1M | $49.0M |
| Q4 25 | $50.2M | $375.3M | ||
| Q3 25 | $36.1M | $366.5M | ||
| Q2 25 | $38.7M | $371.2M | ||
| Q1 25 | $48.2M | $380.7M | ||
| Q4 24 | $36.9M | $374.2M | ||
| Q3 24 | $40.4M | $375.6M | ||
| Q2 24 | $44.8M | $375.0M | ||
| Q1 24 | $51.8M | $369.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $-303.0K |
| Free Cash FlowOCF − Capex | — | $-367.0K |
| FCF MarginFCF / Revenue | — | -12.9% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | — | -1.00× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-377.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $-303.0K | ||
| Q3 25 | $-6.2M | $450.0K | ||
| Q2 25 | $-10.3M | $-86.0K | ||
| Q1 25 | $-9.0M | $-155.0K | ||
| Q4 24 | $-25.6M | $1.4M | ||
| Q3 24 | $-5.1M | $-1.4M | ||
| Q2 24 | $-7.3M | $-1.5M | ||
| Q1 24 | $-5.7M | $-176.0K |
| Q4 25 | — | $-367.0K | ||
| Q3 25 | — | $445.0K | ||
| Q2 25 | — | $-235.0K | ||
| Q1 25 | — | $-220.0K | ||
| Q4 24 | — | $1.4M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-191.0K |
| Q4 25 | — | -12.9% | ||
| Q3 25 | — | 16.7% | ||
| Q2 25 | — | -9.7% | ||
| Q1 25 | — | -9.9% | ||
| Q4 24 | — | 61.8% | ||
| Q3 24 | — | -70.2% | ||
| Q2 24 | — | -77.7% | ||
| Q1 24 | — | -10.4% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | — | -1.00× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | — | -22.14× | ||
| Q4 24 | — | 111.31× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
